Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement

British Journal of Cancer

Volumn 112, Issue 2, 2015, Pages 251-259

  Collins, G S ^a   Reitsma, J B ^b   Altman, D G ^a   Moons, K G M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diagnostic; Model development; Model validation; Prediction models; Prognostic; Transparent reporting

Indexed keywords

CHECKLIST; DECISION MAKING; FUNDING; HEALTH CARE PERSONNEL; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; REVIEW; TELECONFERENCE; TRANSPARENT REPORTING OF A MULTIVARIABLE PREDICTION MODEL FOR INDIVIDUAL PROGNOSIS OR DIAGNOSIS STATEMENT; VALIDATION STUDY; CONSENSUS DEVELOPMENT; METHODOLOGY; NEOPLASMS; STATISTICAL MODEL;

HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RESEARCH DESIGN;

EID: 84921931906     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.639     Document Type: Review

References (56)

1. Altman DG, McShane LM, Sauerbrei W, Taube SE (2012) Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med 10: 51.
2. Altman DG, Vergouwe Y, Royston P, Moons KGM (2009) Prognosis and prognostic research: Validating a prognostic model. BMJ 338: b605.
3. Anderson KM, Odell PM, Wilson PWF, Kannel WB (1991) Cardiovascular disease risk profiles. Am Heart J 121: 293-298.
4. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology 226: 24-28.
5. Bouwmeester W, Zuithoff NP, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, Altman DG, Moons KG (2012) Reporting and methods in clinical prediction research: a systematic review. PLoS Med 9: 1-12.
6. Collins GS, de Groot JA, Dutton S, Omar O, Shanyinde M, Tajar A, Voysey M, Wharton R, Yu LM, Moons KG, Altman DG (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14: 40.
7. Collins GS, Mallett S, Omar O, Yu LM (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9: 103.
8. Collins GS, Michaëlsson K (2012) Fracture risk assessment: state of the art, methodologically unsound, or poorly reported? Curr Osteoporos Rep 10: 199-207.
9. Collins GS, Moons KG (2012) Comparing risk prediction models. BMJ 344: e3186.
10. Collins GS, Omar O, Shanyinde M, Yu LM (2013) A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol 66: 268-277.
11. Dorresteijn JA, Visseren FL, Ridker PM, Wassink AM, Paynter NP, Steyerberg EW, van der Graaf Y, Cook NR (2011) Estimating treatment effects for individual patients based on the results of randomised clinical trials. BMJ 343: d5888.
12. Ettema RG, Peelen LM, Schuurmans MJ, Nierich AP, Kalkman CJ, Moons KG (2010) Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation 122: 682-689.
13. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson J, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith Jr SC, Tomaselli GF (2014) 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129: S49-S73.
14. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K (1982) A prognostic index in primary breast cancer. Br J Cancer 45: 363-366.
15. Hayward RA, Kent DM, Vijan S, Hofer TP (2006) Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol 6: 18.
16. Hemingway H, Riley RD, Altman DG (2009) Ten steps towards improving prognosis research. BMJ 339: b4184.
17. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ (2011a) Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest 41: 1010-1035.
18. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ (2011b) Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest 41: 1004-1009.
19. Järvinen TL, Jokihaara J, Guy P, Alonso-Coello P, Collins GS, Michaëlsson K, Sievänen H (2014) Conflicts at the heart of the FRAX tool. CMAJ 185: 165-167.
20. Justice AC, Covinsky KE, Berlin JA (1999) Assessing the generalizability of prognostic information. Ann Intern Med 130: 515-524.
21. Knottnerus JA (1995) Diagnostic prediction rules: principles, requirements and pitfalls. Prim Care 22: 341-363.
22. Laine C, Goodman SN, Griswold ME, Sox HC (2007) Reproducible research: moving toward research the public can really trust. Ann Intern Med 146: 450-453.
23. Laupacis A, Sekar N, Stiell IG (1997) Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277: 488-494.
24. Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) A simplified acute physiology score for ICU patients. Crit Care Med 12: 975-977.
25. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N (2009) STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 6: e22.
26. Mallett S, Royston P, Dutton S, Waters R, Altman DG (2010) Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 8: 20.
27. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97: 1180-1184.
28. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269.
29. Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research reporting guidelines. PLoS Med 16: e1000217.
30. Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, Reitsma JB, Collins GS (2014) Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist. PLoS Med 11(10): e1001744.
31. Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M (2012a) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98: 691-698.
32. Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE (2012b) Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98: 683-690.
33. Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann Intern Med 162: W1-W73.
34. Moons KGM, Altman DG, Vergouwe Y, Royston P (2009a) Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338: b606.
35. Moons KGM, Royston P, Vergouwe Y, Grobbee DE, Altman DG (2009b) Prognosis and prognostic research: what, why, and how? BMJ 338: b375.
36. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16: 9-13.
37. Rabar S, Lau R, O'Flynn N, Li L, Barry P (2012) Risk assessment of fragility fractures: summary of NICE guidance. BMJ 345: e3698.
38. Reilly BM, Evans AT (2006) Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 144: 201-209.
39. Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, Malats N, Briggs A, Schroter S, Altman DG, Hemingway H (2013) Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 10: e1001380.
40. Royston P, Moons KGM, Altman DG, Vergouwe Y (2009) Prognosis and prognostic research: Developing a prognostic model. BMJ 338: b604.
41. Seel RT, Steyerberg EW, Malec JF, Sherer M, Macciocchi SN (2012) Developing and evaluating prediction models in rehabilitation populations. Arch Phys Med Rehabil 93: S138-S153.
42. Siontis GC, Tzoulaki I, Siontis KC, Ioannidis JP (2012) Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 344: e3318.
43. Steyerberg EW (2009) Clinical prediction models: a practical approach to development, validation, and updating. Springer: New York.
44. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KGM (2003) Internal and external validation of predictive models: A simulation study of bias and precision in small samples. J Clin Epidemiol 56: 441-447.
45. Steyerberg EW, Eijkemans MJC, Habbema JDF (2001a) Application of shrinkage techniques in logistic regression analysis: a case study. Statistica Neerlandica 55: 76-88.
46. Steyerberg EW, Harrell FE, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbema JDF (2001b) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781.
47. Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG (2013) Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research. PLoS Med 10: e1001381.
48. Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B (2012) Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest 42: 216-228.
49. Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR (1992) A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med 21: 384-390.
50. Stiell IG, Wells GA, McKnight D, Brison R, Lesiuk H, Clement CM, Eisenhauer MA, Greenberg GH, MacPhail I, Reardon M, Worhington J, Verbeek R, Dreyer J, Cass D, Schull M, Morrison L, Rowe B, Holroyd B, Bandiera G, Laupacis A (2002a) Canadian C-Spine Rule study for alert and stable trauma patients: I. Background and rationale. CJEM 4: 84-90.
51. Stiell IG, Wells GA, McKnight D, Brison R, Lesiuk H, Clement CM, Eisenhauer MA, Greenberg GH, MacPhail I, Reardon M, Worhington J, Verbeek R, Dreyer J, Cass D, Schull M, Morrison L, Rowe B, Holroyd B, Bandiera G, Laupacis A (2002b) Canadian C-Spine Rule study for alert and stable trauma patients: II. Study objectives and methodology. CJEM 4: 185-193.
52. Tzoulaki I, Liberopoulos G, Ioannidis JP (2011) Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol 40: 1094-1105.
53. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835.
54. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335: 806-808.
55. Wallace E, Smith SM, Perera-Salazar R, Vaucher P, McCowan C, Collins G, Verbakel J, Lakhanpaul M, Fahey T (2011) Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs). BMC Med Inform Decis Mak 11: 62.
56. Williams RJ, Tse T, Harlan WR, Zarin DA (2010) Registration of observational studies: Is it time? CMAJ 182: 1638-1642.